In neurodegenerative conditions such as Alzheimer’s disease (AD), Parkinson’s disease (PD), and amyotrophic lateral sclerosis (ALS), Lgals3 has been established as a biomarker in serum, plasma, and/or cerebrospinal fluid (CSF) [33]. The gene discussed is LGALS3; the disease is Parkinson disease.